Health
Azithromycin use for treating COVID-19 may increase risk of cardiac events – News-Medical.net
Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of COVID-19 have revolved around the drug’s reputation for causing cardiac events such as abnormal heart rhythms or beats and cardiac arrest.
Reviewed by Emily Henderson, B.Sc.Sep 16 2020
Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of COVID-19 have revolved around the drug’s reputation for causing cardiac events such as abnormal heart rhythms or beats and cardiac arrest. Because of this, the U.S. Food and Drug Administration has revoked emergency use authorization for the drug in treating COVID-19.
Another drug, azithromycin — a commonly-prescribed antibiotic — also is being inves…
-
Noosa News18 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News24 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Business23 hours agoAre BHP shares are buy after its results?
-
Noosa News10 hours agoItalian Film Festival, Brisbane: All the Details